航位推算系统非线性过程处理新方法研究

针对航位推算系统中利用扩展Kalman滤波方法解决非线性问题在算法复杂性上的缺陷和精度上的不稳定性,该文从数据预先处理的角度出发,合理规避线性化过程,提出一种充分利用现成Kalman滤波公式的方法,即数据进入滤波器之前就预先进行处理,获得每一组量测值,按照极坐标-笛卡儿坐标的转换方式转为相应的位置信息,再按照标准的Kalman滤波公式构建滤波器,进行状态的最优估计。计算机仿真结果证明该算法的有效性。     

鞍山市生态资源与环境质量的遥感数据分析

利用美国陆地卫星资源LandsatTM遥感监测数据,参考相关图件,进行解译判别,监测鞍山市区及各县区土地类型、土地退化类型,并结合水资源的调查结果,对鞍山市生态环境质量进行评价,分析结果表明,鞍山市全境存在一定程度的土壤侵蚀现象,但基本上为微度侵蚀,重度侵蚀和中度侵蚀面积较小;鞍山市区和台安县生态环境状况指数一般,较适合人类生存,岫岩县和海城市生态环境状况指数良好,生物多样性较好,基本适合人类生存。     

Model Uncertainty and Bayesian Model Averaged Benchmark Dose Estimation for Continuous Data

The benchmark dose (BMD) approach has gained acceptance as a valuable risk assessment tool, but risk assessors still face significant challenges associated with selecting an appropriate BMD/BMDL estimate from the results of a set of acceptable dose‐response models. Current approaches do not explicitly address model uncertainty, and there is an existing need to more fully inform health risk assessors in this regard. In this study, a Bayesian model averaging (BMA) BMD estimation method taking model uncertainty into account is proposed as an alternative to current BMD estimation approaches for continuous data. Using the “hybrid” method proposed by Crump, two strategies of BMA, including both “maximum likelihood estimation based” and “Markov Chain Monte Carlo based” methods, are first applied as a demonstration to calculate model averaged BMD estimates from real continuous dose‐response data. The outcomes from the example data sets examined suggest that the BMA BMD estimates have higher reliability than the estimates from the individual models with highest posterior weight in terms of higher BMDL and smaller 90th percentile intervals. In addition, a simulation study is performed to evaluate the accuracy of the BMA BMD estimator. The results from the simulation study recommend that the BMA BMD estimates have smaller bias than the BMDs selected using other criteria. To further validate the BMA method, some technical issues, including the selection of models and the use of bootstrap methods for BMDL derivation, need further investigation over a more extensive, representative set of dose‐response data.     

A Diversity Index for Model Space Selection in the Estimation of Benchmark and Infectious Doses via Model Averaging

In chemical and microbial risk assessments, risk assessors fit dose‐response models to high‐dose data and extrapolate downward to risk levels in the range of 1–10%. Although multiple dose‐response models may be able to fit the data adequately in the experimental range, the estimated effective dose (ED) corresponding to an extremely small risk can be substantially different from model to model. In this respect, model averaging (MA) provides more robustness than a single dose‐response model in the point and interval estimation of an ED. In MA, accounting for both data uncertainty and model uncertainty is crucial, but addressing model uncertainty is not achieved simply by increasing the number of models in a model space. A plausible set of models for MA can be characterized by goodness of fit and diversity surrounding the truth. We propose a diversity index (DI) to balance between these two characteristics in model space selection. It addresses a collective property of a model space rather than individual performance of each model. Tuning parameters in the DI control the size of the model space for MA.     

元代雕塑家钩沉

本文从古籍中搜罗了１６位未被《中国美术辞典》（沈柔坚主编）收载的元代雕塑家的资料，为中国雕塑史的研究做了史料的发掘工作     

On evaluating how well a biomarker can predict treatment response with survival data

One of the objectives of personalized medicine is to take treatment decisions based on a biomarker measurement. Therefore, it is often interesting to evaluate how well a biomarker can predict the response to a treatment. To do so, a popular methodology consists of using a regression model and testing for an interaction between treatment assignment and biomarker. However, the existence of an interaction is not sufficient for a biomarker to be predictive. It is only necessary. Hence, the use of the marker‐by‐treatment predictiveness curve has been recommended. In addition to evaluate how well a single continuous biomarker predicts treatment response, it can further help to define an optimal threshold. This curve displays the risk of a binary outcome as a function of the quantiles of the biomarker, for each treatment group. Methods that assume a binary outcome or rely on a proportional hazard model for a time‐to‐event outcome have been proposed to estimate this curve. In this work, we propose some extensions for censored data. They rely on a time‐dependent logistic model, and we propose to estimate this model via inverse probability of censoring weighting. We present simulations results and three applications to prostate cancer, liver cirrhosis, and lung cancer data. They suggest that a large number of events need to be observed to define a threshold with sufficient accuracy for clinical usefulness. They also illustrate that when the treatment effect varies with the time horizon which defines the outcome, then the optimal threshold also depends on this time horizon.     

贸易开放对中国水环境污染影响的实证研究

文章基于2004-2013年中国31个省市的面板数据,采用动态面板模型和差分GMM估计方法,分别选取化学需氧量排放和氨氮排放作为水环境污染的有机污染物和无机污染物的排放指标,对贸易开放的结构效应引致的中国水环境污染排放进行了实证研究.研究结果表明,经济增长的规模和技术效应是影响水环境污染排放的主要因素,直接结构效应对中国水污染排放的影响不显著,贸易开放的结构效应也在一定程度上加剧了中国水环境污染的排放.通过引入贸易开放的相关交叉项进一步对决定贸易结构效应的比较优势来源进行识别,结果发现,对于中国水环境污染排放并不存在所谓的“污染天堂效应”和“要素禀赋效应”.贸易的结构效应会导致西部经济欠发达地区的水污染排放降低,而对中东部经济相对发达地区,贸易的结构效应会引致其水污染排放量的增大和排放强度的加剧.     

基于序化机理的稳健型股票价值投资决策——一个研究框架

面对资本市场风险加剧的现实背景,以"公司经营业绩与股票市场业绩一致趋优"为稳健型投资的核心要素,立足于区间数据表示、会计信息度量两个关键要素,开展稳健型股票价值投资的多准则决策建模研究。面向稳健型投资决策目标,提出满足"稳健性""局部性""全局性"3个特性的序化机理,围绕关键特征选择、特征评价、全序化建模的主体脉络建立系统性多准则决策方法,进而构建"稳健型股票价值投资决策"的研究框架。